Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
University of Pittsburgh
University of Pittsburgh
University of Wisconsin, Madison
University of Wisconsin, Madison
Washington University School of Medicine
Bayer
Seagen Inc.
Boehringer Ingelheim
Bristol-Myers Squibb
Vanderbilt University Medical Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Providence Health & Services
OncoC4, Inc.
GlaxoSmithKline
Genmab
Seagen Inc.
Pfizer
Alpha Tau Medical LTD.
Regeneron Pharmaceuticals
PDS Biotechnology Corp.
University of Colorado, Denver
Eastern Cooperative Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
National Cancer Institute (NCI)
Amgen
Arcus Biosciences, Inc.
Washington University School of Medicine
Inhibrx Biosciences, Inc
Gustave Roussy, Cancer Campus, Grand Paris
Incyte Corporation
Erasca, Inc.
Canadian Cancer Trials Group
GlaxoSmithKline
Taiho Oncology, Inc.
Mayo Clinic
M.D. Anderson Cancer Center
Fulgent Pharma LLC.
AstraZeneca
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Gilead Sciences
R-Pharm
M.D. Anderson Cancer Center
University of Colorado, Denver